Railways Government Departments Closing in 22 days TDR #56522601

Supply Of DENGUE IGM ELISA, HIV 1 & 2 RAPID TEST CONFIRMATION KIT, HEV IGM ELISA TEST, KITS FOR ANTI-HIV 1+2, LEPTOSPIRA IGM ELISA

Issued by Government Departments · , Tamil Nadu
Tender Value
Ref. Documents
Estimated cost
Bid Submission
12 Aug 2026
22 days left
EMD
Ref. Documents
Bank guarantee accepted
Document Fee
Ref. Documents
Non-refundable
Tender Type
Online

Tender Overview

Competition Type
NCB
Bidding Type
Tender
Location / State
→ Tamil Nadu
EMD Exemption
Not Available
Quantity
Not Available

Project Description

Supply Of dengue igm elisa, hiv 1 & 2 rapid test confirmation kit, hev igm elisa test, kits for anti-hiv 1+2, leptospira igm elisa , srphc82670160-hev igm elisa test: 1. assay should be based on the principle of igm capture. 2. the assay should detect igm anti hev antibodies. 3. should be compatible with plasma and serum bot h. 4. the kit size should be 96 tests/kit (in strips of 12x8 wells such that individual strips can be used f or testing and the same are compatible with automated elisa reader and washer. 5. the manufacturer /authorized agent should ensure maintenance of cold chain during storage and transport of kits at 2-8 degree c. 6. original technical data sheet should be provided with each kit. 7. the assay component should include reactive and non-reactive controls sufficient for atleast 4 runs. 8. the assay compon ents should be sufficient for the 96 tests provided in four runs. 9. the assay should have sensitivity g reater than and equal to 99% and specificity greater than and equal to 98%. 10. the kit should have a pproval of the statutory authority from the country of origin. 11. in case of imported kits it should b e registered and licensed by the dcg(i). 12. in case of indigenous manufactures should be licensed by t he competent authority defined under drugs and cosmetics act at 1940 and also be evaluated by the c enters approved by the government of india. 13. the kit should have minimum shelf life of 60% or 12 mo nths(whichever is more) at the time of delivery to consignee. unit:test ] , srphc82670110-dengue igm elisa: 1. assay should be based on the principle of igm capture. 2. the assay should detect igm antibodies against dengue. 3. should be compatible with plasma and ser um both. 4. the kit size should be 96 tests/kit (in strips of 12x8 wells such that individual strips can be used for testing and the same are compatible with standard automated elisa reader and washer. 5. th e manufacturer /authorized agent should ensure maintenance of cold chain during storage and tran sport of kits at 2-8 degree c. 6. original technical data sheet should be provided with each kit. 7. the assay component should include reactive and non-reactive controls sufficient for atleast 4 runs. 8. the assay components should be sufficient for the 96 tests provided in four runs. 9. the assay must be of very high sensitivity greater than and equal to 95% and specificity greater than and equal to 9 8%. 10. the kit should have approval of the statutory authority from the country of origin. 11. in cas e of imported kits it should be registered and licensed by the dcg(i). 12. in case of indigenous manufac tures should be licensed by the competent authority defined under drugs and cosmetics act at 1940 a nd also be evaluated by the centres approved by the government of india. 13. the kit should have mini mum shelf life of 60% or 12 months (whichever is more) at the time of delivery to consignee. unit:test ] , srphc82670205-leptospira igm elisa :1.kit should be able to detect igm antibodies against l eptospira antigen in human serum. 2. should be a solid phase enzyme-linked immunosorbent assay (elisa ) based on the sandwich principle. 3. should be compatible with all common elisa reader. 4. the assay c omponent should include reactive and non- reactive controls. 5.test should have a sensitivity of gre ater than and equal to 97% and specificity of greater than and equal to 99%. 6.adequate documents detailing principle, components, bio safety, methodologies, limitations of assays, manufacturing & expi ry dates should be provided with each kit. 7. the kit to be procured should have approval of the stat utory authority in its country of origin. 8. in case of imported kits it should have been registered and licensed in india by dcg (i). 9. in case of indigenous manufacturers they shall have license issued by the competent authority defined under drugs and cosmetics act, 1940 after appropriate evaluation by the centers approved by dcg (i). 10. the kit should have minimum shelf life of 18 months 1to 30 degree celsius. 11. kit for 96 tests. unit:test ] , srphc82670200-kits for anti-hiv 1+2: 1. should be based on immunofiltration membrane (flo w through). 2. should have antigen immobilised on immunofiltration membrane. 3. should be 3rd gener ation i.e. include detection of to hiv 1 & 2 ab. 3. should have in built quality control band or dot. 4. sh ould have short interpretation time not more than 30 minutes. 5. should have specificity and sensitivit y of 100%. 6. should be approved and evaluated by nib. unit:test ] , srphc82670170-hiv 1 & 2 rapid test confirmation kit unit:test ]

BOQ

Sl. No.Item Description
1SRPHC82670160-HEV IGM ELISA TEST: 1. ASSAY SHOULD BE BASED ON THE PRINCIPLE OF IGM CAPTURE. 2. THE ASSAY SHOULD DETECT IGM ANTI HEV ANTIBODIES. 3. SHOULD BE COMPATIBLE WITH PLASMA AND SERUM BOT H. 4. THE KIT SIZE SHOULD BE 96 TESTS/KIT (IN STRIPS OF 12X8 WELLS SUCH THAT INDIVIDUAL STRIPS CAN BE USED F OR TESTING AND THE SAME ARE COMPATIBLE WITH AUTOMATED ELISA READER AND WASHER. 5. THE MANUFACTURER /AUTHORIZED AGENT SHOULD ENSURE MAINTENANCE OF COLD CHAIN DURING STORAGE AND TRANSPORT OF KITS AT 2-8 DEGREE C. 6. ORIGINAL TECHNICAL DATA SHEET SHOULD BE PROVIDED WITH EACH KIT. 7. THE ASSAY COMPONENT SHOULD INCLUDE REACTIVE AND NON-REACTIVE CONTROLS SUFFICIENT FOR ATLEAST 4 RUNS. 8. THE ASSAY COMPON ENTS SHOULD BE SUFFICIENT FOR THE 96 TESTS PROVIDED IN FOUR RUNS. 9. THE ASSAY SHOULD HAVE SENSITIVITY G REATER THAN AND EQUAL TO 99% AND SPECIFICITY GREATER THAN AND EQUAL TO 98%. 10. THE KIT SHOULD HAVE A PPROVAL OF THE STATUTORY AUTHORITY FROM THE COUNTRY OF ORIGIN. 11. IN CASE OF IMPORTED KITS IT SHOULD B E REGISTERED AND LICENSED BY THE DCG(I). 12. IN CASE OF INDIGENOUS MANUFACTURES SHOULD BE LICENSED BY T HE COMPETENT AUTHORITY DEFINED UNDER DRUGS AND COSMETICS ACT AT 1940 AND ALSO BE EVALUATED BY THE C ENTERS APPROVED BY THE GOVERNMENT OF INDIA. 13. THE KIT SHOULD HAVE MINIMUM SHELF LIFE OF 60% OR 12 MO NTHS(WHICHEVER IS MORE) AT THE TIME OF DELIVERY TO CONSIGNEE. UNIT:TEST ]
2SRPHC82670110-DENGUE IGM ELISA: 1. ASSAY SHOULD BE BASED ON THE PRINCIPLE OF IGM CAPTURE. 2. THE ASSAY SHOULD DETECT IGM ANTIBODIES AGAINST DENGUE. 3. SHOULD BE COMPATIBLE WITH PLASMA AND SER UM BOTH. 4. THE KIT SIZE SHOULD BE 96 TESTS/KIT (IN STRIPS OF 12X8 WELLS SUCH THAT INDIVIDUAL STRIPS CAN BE USED FOR TESTING AND THE SAME ARE COMPATIBLE WITH STANDARD AUTOMATED ELISA READER AND WASHER. 5. TH E MANUFACTURER /AUTHORIZED AGENT SHOULD ENSURE MAINTENANCE OF COLD CHAIN DURING STORAGE AND TRAN SPORT OF KITS AT 2-8 DEGREE C. 6. ORIGINAL TECHNICAL DATA SHEET SHOULD BE PROVIDED WITH EACH KIT. 7. THE ASSAY COMPONENT SHOULD INCLUDE REACTIVE AND NON-REACTIVE CONTROLS SUFFICIENT FOR ATLEAST 4 RUNS. 8. THE ASSAY COMPONENTS SHOULD BE SUFFICIENT FOR THE 96 TESTS PROVIDED IN FOUR RUNS. 9. THE ASSAY MUST BE OF VERY HIGH SENSITIVITY GREATER THAN AND EQUAL TO 95% AND SPECIFICITY GREATER THAN AND EQUAL TO 9 8%. 10. THE KIT SHOULD HAVE APPROVAL OF THE STATUTORY AUTHORITY FROM THE COUNTRY OF ORIGIN. 11. IN CAS E OF IMPORTED KITS IT SHOULD BE REGISTERED AND LICENSED BY THE DCG(I). 12. IN CASE OF INDIGENOUS MANUFAC TURES SHOULD BE LICENSED BY THE COMPETENT AUTHORITY DEFINED UNDER DRUGS AND COSMETICS ACT AT 1940 A ND ALSO BE EVALUATED BY THE CENTRES APPROVED BY THE GOVERNMENT OF INDIA. 13. THE KIT SHOULD HAVE MINI MUM SHELF LIFE OF 60% OR 12 MONTHS (WHICHEVER IS MORE) AT THE TIME OF DELIVERY TO CONSIGNEE. UNIT:TEST ]
3SRPHC82670205-LEPTOSPIRA IGM ELISA :1.KIT SHOULD BE ABLE TO DETECT IGM ANTIBODIES AGAINST L EPTOSPIRA ANTIGEN IN HUMAN SERUM. 2. SHOULD BE A SOLID PHASE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA ) BASED ON THE SANDWICH PRINCIPLE. 3. SHOULD BE COMPATIBLE WITH ALL COMMON ELISA READER. 4. THE ASSAY C OMPONENT SHOULD INCLUDE REACTIVE AND NON- REACTIVE CONTROLS. 5.TEST SHOULD HAVE A SENSITIVITY OF GRE ATER THAN AND EQUAL TO 97% AND SPECIFICITY OF GREATER THAN AND EQUAL TO 99%. 6.ADEQUATE DOCUMENTS DETAILING PRINCIPLE, COMPONENTS, BIO SAFETY, METHODOLOGIES, LIMITATIONS OF ASSAYS, MANUFACTURING & EXPI RY DATES SHOULD BE PROVIDED WITH EACH KIT. 7. THE KIT TO BE PROCURED SHOULD HAVE APPROVAL OF THE STAT UTORY AUTHORITY IN ITS COUNTRY OF ORIGIN. 8. IN CASE OF IMPORTED KITS IT SHOULD HAVE BEEN REGISTERED AND LICENSED IN INDIA BY DCG (I). 9. IN CASE OF INDIGENOUS MANUFACTURERS THEY SHALL HAVE LICENSE ISSUED BY THE COMPETENT AUTHORITY DEFINED UNDER DRUGS AND COSMETICS ACT, 1940 AFTER APPROPRIATE EVALUATION BY THE CENTERS APPROVED BY DCG (I). 10. THE KIT SHOULD HAVE MINIMUM SHELF LIFE OF 18 MONTHS 1TO 30 DEGREE CELSIUS. 11. KIT FOR 96 TESTS. UNIT:TEST ]
4SRPHC82670200-KITS FOR ANTI-HIV 1+2: 1. SHOULD BE BASED ON IMMUNOFILTRATION MEMBRANE (FLO W THROUGH). 2. SHOULD HAVE ANTIGEN IMMOBILISED ON IMMUNOFILTRATION MEMBRANE. 3. SHOULD BE 3RD GENER ATION I.E. INCLUDE DETECTION OF TO HIV 1 & 2 AB. 3. SHOULD HAVE IN BUILT QUALITY CONTROL BAND OR DOT. 4. SH OULD HAVE SHORT INTERPRETATION TIME NOT MORE THAN 30 MINUTES. 5. SHOULD HAVE SPECIFICITY AND SENSITIVIT Y OF 100%. 6. SHOULD BE APPROVED AND EVALUATED BY NIB. UNIT:TEST ]
5SRPHC82670170-HIV 1 & 2 RAPID TEST CONFIRMATION KIT UNIT:TEST ]

AI Tender Summary

OUR REF NO 56522601
AUTHORITY Government Departments
TENDER VALUE Ref. Documents
LAST DATE 12-08-2026
Authority
Authority Name Southern Railway
Work Description Supply Of dengue igm elisa, hiv 1 & 2 rapid test confirmation kit, hev igm elisa test, kits for anti-hiv 1+2, leptospira igm elisa , srphc82670160-hev igm elisa test: 1. assay should be based on the principle of igm capture. 2. the assay should detect igm anti hev antibodies. 3. should be compatible with plasma and serum bot h. 4. the kit size should be 96 tests/kit (in strips of 12x8 wells such that individual strips can be used f or testing and the same are compatible with automated elisa reader and washer. 5. the manufacturer /authorized agent should ensure maintenance of cold chain during storage and transport of kits at 2-8 degree c. 6. original technical data sheet should be provided with each kit. 7. the assay component should include reactive and non-reactive controls sufficient for atleast 4 runs. 8. the assay compon ents should be sufficient for the 96 tests provided in four runs. 9. the assay should have sensitivity g reater than and equal to 99% and specificity greater than and equal to 98%. 10. the kit should have a pproval of the statutory authority from the country of origin. 11. in case of imported kits it should b e registered and licensed by the dcg(i). 12. in case of indigenous manufactures should be licensed by t he competent authority defined under drugs and cosmetics act at 1940 and also be evaluated by the c enters approved by the government of india. 13. the kit should have minimum shelf life of 60% or 12 mo nths(whichever is more) at the time of delivery to consignee. unit:test ] , srphc82670110-dengue igm elisa: 1. assay should be based on the principle of igm capture. 2. the assay should detect igm antibodies against dengue. 3. should be compatible with plasma and ser um both. 4. the kit size should be 96 tests/kit (in strips of 12x8 wells such that individual strips can be used for testing and the same are compatible with standard automated elisa reader and washer. 5. th e manufacturer /authorized agent should ensure maintenance of cold chain during storage and tran sport of kits at 2-8 degree c. 6. original technical data sheet should be provided with each kit. 7. the assay component should include reactive and non-reactive controls sufficient for atleast 4 runs. 8. the assay components should be sufficient for the 96 tests provided in four runs. 9. the assay must be of very high sensitivity greater than and equal to 95% and specificity greater than and equal to 9 8%. 10. the kit should have approval of the statutory authority from the country of origin. 11. in cas e of imported kits it should be registered and licensed by the dcg(i). 12. in case of indigenous manufac tures should be licensed by the competent authority defined under drugs and cosmetics act at 1940 a nd also be evaluated by the centres approved by the government of india. 13. the kit should have mini mum shelf life of 60% or 12 months (whichever is more) at the time of delivery to consignee. unit:test ] , srphc82670205-leptospira igm elisa :1.kit should be able to detect igm antibodies against l eptospira antigen in human serum. 2. should be a solid phase enzyme-linked immunosorbent assay (elisa ) based on the sandwich principle. 3. should be compatible with all common elisa reader. 4. the assay c omponent should include reactive and non- reactive controls. 5.test should have a sensitivity of gre ater than and equal to 97% and specificity of greater than and equal to 99%. 6.adequate documents detailing principle, components, bio safety, methodologies, limitations of assays, manufacturing & expi ry dates should be provided with each kit. 7. the kit to be procured should have approval of the stat utory authority in its country of origin. 8. in case of imported kits it should have been registered and licensed in india by dcg (i). 9. in case of indigenous manufacturers they shall have license issued by the competent authority defined under drugs and cosmetics act, 1940 after appropriate evaluation by the centers approved by dcg (i). 10. the kit should have minimum shelf life of 18 months 1to 30 degree celsius. 11. kit for 96 tests. unit:test ] , srphc82670200-kits for anti-hiv 1+2: 1. should be based on immunofiltration membrane (flo w through). 2. should have antigen immobilised on immunofiltration membrane. 3. should be 3rd gener ation i.e. include detection of to hiv 1 & 2 ab. 3. should have in built quality control band or dot. 4. sh ould have short interpretation time not more than 30 minutes. 5. should have specificity and sensitivit y of 100%. 6. should be approved and evaluated by nib. unit:test ] , srphc82670170-hiv 1 & 2 rapid test confirmation kit unit:test ]
Basic Detail
Tender No 02265889
Bidding Type Tender
Location
City
State Tamil Nadu
Key Dates
Publish Date 17 Jul 2026
Submission Date 12 Aug 2026
Open Date 01 Jan 0001
Finance
Tender Value Ref. Documents
Tender Fee Ref. Documents
EMD Ref. Documents
Exemption Not Available
Document List
9bbca686-7d9d-4f21-982f-446843504971.pdf

Unlock Full AI Tender Summary

Get instant access to the complete AI-generated analysis — scope, eligibility, timeline & more.

Instant Access Secure Free
Your details are secure and used only for document delivery.

Tender Timeline

Jul 17, 2026
11:30 IST

Tender Published

Tender notice published.

Completed
Aug 12, 2026
17:00 IST

Bid Submission Deadline

Online submission via eProcurement portal.

Upcoming · 22 days

Tender Documents

Download All (ZIP) ↓
pdf

9bbca686-7d9d-4f21-982f-446843504971.pdf

Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

TenderDetail
Loading tenders